Why the study?
Echocardiography is essential for diagnosing, evaluating, and risk-stratifying HCM, and newer techniques now reveal subtle changes in these patients.
Echocardiography, including advanced modalities like strain and 3D imaging, remains the cornerstone for diagnosing, functionally assessing, and risk-stratifying patients with hypertrophic cardiomyopathy.
Affirms echocardiography's central role in HCM care; leaves open prospective validation of strain imaging for preclinical detection.
Hypertrophic cardiomyopathy (HCM) is the most common non-ischemic cardiomyopathy, characterized by increased left ventricular wall thickness. Echocardiographic studies are essential for establishing the diagnosis, evaluating the extent of disease, and risk stratification. Echocardiography is also recommended in regular screening of the genotype-positive relatives. Two-dimensional, M-mode, and Doppler echocardiography are standard modalities in HCM diagnosis. Newer echocardiographic techniques as tissue Doppler, strain, and three-dimensional echocardiography are now widely used and can reveal subtle changes in the HCM patients. Echocardiography has given us a better understanding of the disease. In this review, we briefly profile the echocardiographic management of HCM in a clinical perspective.
No takes yet. Share an insight, caveat, or question.
Trine F. Håland (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: